NCT00498992Unknown不适用
Regenecare® in the Treatment of Skin Rash Associated With Cetuximab (Erbitux®) or Other EGFR Treated Cancer Patients
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Efficacy of Regenecare® wound gel, in terms of alleviating pain and itching
研究概览
简要总结
RATIONALE: Regenecare® wound gel may help relieve pain and itching in patients who develop an acne-like rash while undergoing treatment with cetuximab or another epidermal growth factor receptor inhibitor for cancer.
PURPOSE: This clinical trial is studying how well Regenecare® wound gel works in treating rash in patients receiving cetuximab or another epidermal growth factor receptor inhibitor therapy for cancer.
详细描述
OBJECTIVES:
Primary
- Determine the efficacy of Regenecare® wound gel in alleviating pain and itching in patients who develop an acneiform rash while undergoing treatment with cetuximab or other EGFR inhibitor therapy for cancer.
Secondary
- Determine the efficacy of this drug in reducing the severity of rash in these patients.
- Determine the efficacy of this drug in reducing the redness and appearance of the rash in these patients.
- Determine the tolerability of this drug in these patients.
研究设计
- 研究类型
- Interventional
- 主要目的
- Supportive Care
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Efficacy of Regenecare® wound gel, in terms of alleviating pain and itching
次要结局
- Efficacy of Regenecare® wound gel, in terms of reducing severity, redness, and appearance of rash
- Tolerability of Regenecare® wound gel as assessed by NCI CTCAE v3.0
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With RadiotherapyHead and Neck CancerNCT01520701Centre Francois Baclesse130
已完成
2 期
Retinyl Palmitate-loaded Ethosomes in Acne VulgarisFacial Acne VulgarisNCT04080869Assiut University20
已完成
不适用
aser versus conventional treatment for active acne in primary careISRCTN78675673West London Research Network (WeLReN) (UK)40
撤回
不适用
A Novel Skin Barrier Protectant for Acute RadiodermatitisRadiation ToxicityRadiation DermatitisSkin DiseasesHead and Neck CancerRadiodermatitisNCT04593914Jessa Hospital
终止
2 期
Beta Blocker for Chronic Wound HealingUlcerBurnsNCT00368602University of California, Davis40